A randomized double-blind clinical trial on safety and efficacy of tauroursodeoxycholic acid (TUDCA) as add-on treatment in patients affected by amyotrophic lateral sclerosis (ALS): the statistical analysis plan of TUDCA-ALS trial.
Trials
; 24(1): 792, 2023 Dec 05.
Article
em En
| MEDLINE
| ID: mdl-38053196
Palavras-chave
Texto completo:
1
Coleções:
01-internacional
Base de dados:
MEDLINE
Assunto principal:
Fármacos Neuroprotetores
/
Esclerose Lateral Amiotrófica
Limite:
Humans
Idioma:
En
Revista:
Trials
Ano de publicação:
2023
Tipo de documento:
Article